Kazia Therapeutics Limited Analysis
| Analyst Ratings |
|
Average Target Price
|
10.57
|
|
Average Rating
|
3.00
|
|
# Strong Buys
|
0
|
|
# Buys
|
0
|
|
# Holds
|
1
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2021-03-31
|
0.00
|
-0.01
|
-0.01
|
0.00%
|
|
2020-12-31
|
0.00
|
-0.01
|
-0.01
|
0.00%
|
|
2020-09-30
|
0.00
|
-0.02
|
-0.02
|
0.00%
|
|
2020-06-30
|
0.00
|
-0.02
|
-0.02
|
0.00%
|
|
2020-03-31
|
0.00
|
-0.03
|
-0.03
|
0.00%
|
|
2019-12-31
|
0.00
|
-0.03
|
-0.03
|
0.00%
|
|
2019-09-30
|
0.00
|
-0.03
|
-0.03
|
0.00%
|
|
2019-06-30
|
0.00
|
-0.03
|
-0.03
|
0.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2021-03-31
|
-0.03
|
|
2020-06-30
|
-0.11
|
|
2019-06-30
|
-0.12
|
|
2018-06-30
|
-0.08
|
|
2017-06-30
|
-0.46
|
|
2016-06-30
|
-0.23
|
|
2015-06-30
|
-0.21
|
|
2014-06-30
|
-0.39
|
|
2013-06-30
|
-0.11
|
|
2012-06-30
|
0.09
|
|
2011-06-30
|
-0.46
|